Related Experiment Video
Updated: Aug 21, 2026
06:01
Prion Safety Laboratory Swipe Test
Published on: February 14, 2025
Barriers to Creutzfeldt-Jakob disease autopsies, California
Janice K Louie1, Shilpa S Gavali, Ermias D Belay
1California Emerging Infections Program, Richmond, California, USA. jlouie@dhs.ca.gov
Emerging Infectious Diseases
|October 23, 2004
Abstract:
Creutzfeldt-Jakob disease (CJD) surveillance relies on autopsy and neuropathologic evaluation. The 1990-2000 CJD autopsy rate in California was 21%. Most neurologists were comfortable diagnosing CJD (83%), but few pathologists felt comfortable diagnosing CJD (35%) or performing autopsy (29%). Addressing obstacles to autopsy is necessary to improve CJD surveillance.
